P067 - Predictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting
| Autor: | Omrcen, T., Eterovic, D., Vrdoljak, E. |
|---|---|
| Zdroj: | In European Urology Supplements November 2019 18(11):e3491-e3492 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect